Xanthobacter sp C20 contains a novel bioconversion pathway for limonene

Citation
Mj. Van Der Werf et al., Xanthobacter sp C20 contains a novel bioconversion pathway for limonene, J BIOTECH, 84(2), 2000, pp. 133-143
Citations number
29
Categorie Soggetti
Biotecnology & Applied Microbiology",Microbiology
Journal title
JOURNAL OF BIOTECHNOLOGY
ISSN journal
01681656 → ACNP
Volume
84
Issue
2
Year of publication
2000
Pages
133 - 143
Database
ISI
SICI code
0168-1656(20001130)84:2<133:XSCCAN>2.0.ZU;2-2
Abstract
Xanthobacter sp. C20 was isolated from sediment of the river Rhine using cy clohexane as sole source of carbon and energy. Xanthobacter sp. C20 convert ed both enantiomers of limonene quantitatively into limonene-8,9-epoxide, a not previously described bioconversion product of limonene. With (4R)-limo nene, (4R,8R)-limonene-8,9-epoxide was formed as the only reaction product, while (4S)-limonene was converted into a (78:22) mixture of (4S,8R)- and ( 4S,8S)-limonene-8,9-epoxide. Cytochrome P-450 was shown to be induced conco mitantly with limonene bioconversion activity following growth of Xantobact er sp. C20 on cyclohexane. Maximal limonene bioconversion rate was observed at an initial substrate concentration of 12 mM. The amount of limonene-8,9 -epoxide formed, up to 0.8 g l(-1), was limited by a strong product inhibit ion. (C) 2000 Elsevier Science B.V. All rights reserved.